Nivolumab or atezolizumab in the second-line treatment of advanced non-small-cell lung cancer? Prognostic index based on real-world data

被引：0
|
作者：
Knetki-Wroblewska, M. [1 ]
Pluzanski, A. [1 ]
Tabor, S. [1 ]
Winiarczyk, K. [1 ]
Zaborowska-Szmit, M. [1 ]
Zajda, K. [1 ]
Zebrowska, A. Janowicz [1 ]
Piorek, A. [1 ]
Badurak, P. [1 ]
Jaskiewicz, P. [1 ]
Kowalski, D. M. [1 ]
Krzakowski, M. J. [1 ]
机构：
[1] Maria Sklodowska Curie Natl Res Inst Oncol, Lung Canc & Chest Tumors Dept, Warsaw, Poland
来源：
ANNALS OF ONCOLOGY | 2022年 / 33卷 / 07期
关键词：
D O I：
10.1016/j.annonc.2022.07.1166
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1040P
引用
收藏
页码：S1030 / S1030
页数：1
相关论文
共 50 条
  • [21] Gemcitabine as second-line treatment for advanced non-small-cell lung cancer:: A phase II trial
    Crinò, L
    Mosconi, AM
    Scagliotti, G
    Selvaggi, G
    Novello, S
    Rinaldi, M
    Della Giulia, M
    Gridelli, C
    Rossi, A
    Calandri, C
    De Marinis, F
    Noseda, M
    Tonato, M
    JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (07) : 2081 - 2085
  • [22] Second-line treatment of advanced non-small cell lung cancer
    Gridelli, Cesare
    Ardizzoni, Andrea
    Ciardiello, Fortunato
    Hanna, Nasser
    Heymach, John V.
    Perrone, Francesco
    Rosell, Rafael
    Shepherd, Frances A.
    Thatcher, Nick
    Vansteenkiste, Johan
    De Petris, Luigi
    Di Maio, Massimo
    De Marinis, Filippo
    JOURNAL OF THORACIC ONCOLOGY, 2008, 3 (04) : 430 - 440
  • [23] Real-World Analysis of Nivolumab and Atezolizumab Efficacy in Previously Treated Patients with Advanced Non-Small Cell Lung Cancer
    Alonso-Garcia, Miriam
    Sanchez-Gastaldo, Amparo
    Munoz-Fuentes, Miguel A.
    Molina-Pinelo, Sonia
    Boyero, Laura
    Benedetti, Johana Cristina
    Bernabe-Caro, Reyes
    PHARMACEUTICALS, 2022, 15 (05)
  • [24] Real-World Data on Pembrolizumab for Pretreated Non-Small-Cell Lung Cancer: Clinical Outcome and Relevance of the Lung Immune Prognostic Index
    Ana Ortega-Franco
    Clare Hodgson
    Haseem Raja
    Mathew Carter
    Colin Lindsay
    Sarah Hughes
    Laura Cove-Smith
    Paul Taylor
    Yvonne Summers
    Fiona Blackhall
    Raffaele Califano
    Targeted Oncology, 2022, 17 : 453 - 465
  • [25] Real-World Data on Pembrolizumab for Pretreated Non-Small-Cell Lung Cancer: Clinical Outcome and Relevance of the Lung Immune Prognostic Index
    Ortega-Franco, Ana
    Hodgson, Clare
    Raja, Haseem
    Carter, Mathew
    Lindsay, Colin
    Hughes, Sarah
    Cove-Smith, Laura
    Taylor, Paul
    Summers, Yvonne
    Blackhall, Fiona
    Califano, Raffaele
    TARGETED ONCOLOGY, 2022, 17 (04) : 453 - 465
  • [26] Atezolizumab in advanced non-small-cell lung cancer
    Brower, Vicki
    LANCET ONCOLOGY, 2017, 18 (08): : E434 - E434
  • [27] Real-World Treatment Patterns, Overall Survival, and Occurrence and Costs of Adverse Events Associated With Second-Line Therapies for Medicare Patients With Advanced Non-Small-Cell Lung Cancer
    Arunachalam, Ashwini
    Li, Haojie
    Biutoni, Marisa A.
    Camacho, Ramon
    Cao, Xiting
    Zhong, Yichen
    Lubiniecki, Gregory M.
    Carbone, David P.
    CLINICAL LUNG CANCER, 2018, 19 (05) : E783 - E799
  • [28] Prognostic Value of Inflammatory and Nutritional Index in Advanced Stage Non-Small Cell Lung Cancer Patients Treated with Nivolumab in Second-Line Therapy
    Disli, Safak Yildirim
    Ayas, Eyyup
    Disli, Ahmet Kursad
    Ozdemir, Feyyaz
    UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI, 2024, 34 (02): : 68 - 73
  • [29] New avenues for second-line treatment of metastatic non-small-cell lung cancer
    Gridelli, Cesare
    Maione, Paolo
    Rossi, Antonio
    Falanga, Marzia
    Bareschino, Marianna
    Schettino, Clorinda
    Colantuoni, Giuseppe
    Guerriero, Ciro
    Nicolella, Dario
    Rossi, Ernanuela
    Ferrara, Marianna Luciana
    Palazzolo, Giovanni
    EXPERT REVIEW OF ANTICANCER THERAPY, 2009, 9 (01) : 115 - 124
  • [30] Topotecan in a Real-World Small-Cell Lung Cancer Cohort: Prognostic Biomarkers Improve Selection of Patients for Second-Line Treatment
    Lambrecht, Laura
    Arnold, Paola
    Behr, Juergen
    Mertsch, Pontus
    Tufman, Amanda
    Kauffmann-Guerrero, Diego
    DIAGNOSTICS, 2024, 14 (14)
12345